title: Regulation of N-acetylglucosaminyltransferase V by protein kinases.
abstract: When 7721 human hepatocarcinoma cells were treated with 100 nM phorbol-12-myristate-13-acetate (PMA), the activity of N-acetylglucosaminyltransferase V(GnT-V) in the cells varied in accordance with the activity of membranous protein kinase C (PKC), but not with that of cytosolic PKC. Quercetin, a non-specific inhibitor of Ser/Thr protein kinase, and D-sphingosine and staurosporine, two specific inhibitors of PKC, blocked the activation of membranous PKC and GnT-V by PMA. Among the three inhibitors, quercetin was least effective. The inhibitory rates of quercetin and staurosporine toward membranous PKC and GnTV were proportional to the concentrations of the two inhibitors. The activities of GnTV and membranous protein kinase A (PKA) were also induced in parallel by dibutyryl cAMP (db-cAMP) and this induction was blocked by a specific PKA inhibitor. When cell free preparations of 7721 cells and human kidney were treated with alkaline phosphatase (ALP) to remove the phosphate groups, the GnTV activities were decreased. These results suggest that GnTV may be activated by membranous PKC or PKA, indirectly or directly, via phosphorylation of Ser/Thr residues.
authors: Department of Biochemistry, Shanghai Medical University, China.
authors: T Z
authors: TZ
authors: Ju
authors: H L
authors: HL
authors: Chen
authors: J X
authors: JX
authors: Gu
authors: H
authors: H
authors: Qin
mesh_terms: D000595:Amino Acid Sequence; D003994:Bucladesine / Q000494:pharmacology; D002240:Carbohydrate Sequence; D017868:Cyclic AMP-Dependent Protein Kinases / Q000187:drug effects / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019833:Genistein; D006801:Humans; D007529:Isoflavones / Q000494:pharmacology; D008969:Molecular Sequence Data; D017351:N-Acetylglucosaminyltransferases / Q000187:drug effects / Q000502:physiology*; D011493:Protein Kinase C / Q000187:drug effects / Q000502:physiology*; D011505:Protein-Tyrosine Kinases / Q000187:drug effects / Q000502:physiology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014638:Vanadates / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D007529:Isoflavones; D014638:Vanadates; D003994:Bucladesine; D019833:Genistein; D017351:N-Acetylglucosaminyltransferases; C052254:alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase; D011505:Protein-Tyrosine Kinases; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate